Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 8, 2022
Perioperative Outcomes in Patients Who Underwent Fibula, Osteocutaneous Radial Forearm, and Scapula Free Flaps: A Multicenter Study
Craig Allen Bollig, Amit Walia, Patrik Pipkorn, et al.
Molecular & Cellular Proteomics : MCP
|
September 16, 2023
Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
Nathan T Wamsley, Emily M Wilkerson, Li Guan, et al.
Cell Reports. Medicine
|
April 2, 2026
Single-cell analysis highlights the significance of malignant cell IFN/MHC-II for immunotherapy response in head and neck squamous cell carcinoma
Michael Mints, Reilly A Sample, Anuraag S Parikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2023
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
Miriam T Jacobs, Pamela Wong, Alice Y Zhou, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
October 11, 2019
Complications, Mortality, and Functional Decline in Patients 80 Years or Older Undergoing Major Head and Neck Ablation and Reconstruction
Tanya Fancy, Andrew T Huang, Jason I Kass, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy response
Riley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 8, 2022
Perioperative Outcomes in Patients Who Underwent Fibula, Osteocutaneous Radial Forearm, and Scapula Free Flaps: A Multicenter Study
Craig Allen Bollig, Amit Walia, Patrik Pipkorn, et al.
Molecular & Cellular Proteomics : MCP
|
September 16, 2023
Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
Nathan T Wamsley, Emily M Wilkerson, Li Guan, et al.
Cell Reports. Medicine
|
April 2, 2026
Single-cell analysis highlights the significance of malignant cell IFN/MHC-II for immunotherapy response in head and neck squamous cell carcinoma
Michael Mints, Reilly A Sample, Anuraag S Parikh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 9, 2023
Memory-like Differentiation, Tumor-Targeting mAbs, and Chimeric Antigen Receptors Enhance Natural Killer Cell Responses to Head and Neck Cancer
Miriam T Jacobs, Pamela Wong, Alice Y Zhou, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
October 11, 2019
Complications, Mortality, and Functional Decline in Patients 80 Years or Older Undergoing Major Head and Neck Ablation and Reconstruction
Tanya Fancy, Andrew T Huang, Jason I Kass, et al.
Biorxiv : the Preprint Server for Biology
|
June 12, 2026
High-avidity TCR signaling induces a distinct KLR-positive exhaustion state in human tumor-infiltrating CD8 T cells associated with immunotherapy response
Riley D Z Mullins, Jesse M Zaretsky, Thomas F Barrett, et al.
Science Immunology
|
September 8, 2023
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B Afeyan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 5, 2021
Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2020
Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase II Trial
Ravindra Uppaluri, Katie M Campbell, Ann Marie Egloff, et al.
Page
of 8